| CM/SLN/Ce6
NPs silica NPs (SLN) with cell membrane (CM) |
Ce6 |
680 nm laser, (1 W/cm2) |
90.4 ± 3.2 nm |
+32.4 ± 1.7 mV |
SGC7901 cells |
gastric cancer (PDT) |
(233) |
| SWCNTs-HA-Ce6 (single-walled
carbon nanotubes, hyaluronic acid
(HA) and chlorin e6 (Ce6) |
Ce6 |
660 nm laser
(5 and 10 J/cm2) |
203 ± 6.6 nm |
–18.9 ± 1 mV |
Caco-2 cells |
colon cancer (PDT) |
(234) |
| Ce6-Fu/AL@GG-based hydrogel (Chlorin e6 (Ce6)-fucoidan/alginates@gellam
gum) |
Ce6 |
660 nm laser (4 J/cm2) |
not defined |
not defined |
HT-29 cells |
colon cancer
(PDT) |
(235) |
| Ce6-PDT |
Ce6 |
650 nm, (4 J/cm2) |
not defined |
not defined |
SW620 cells |
colon cancer
(PDT) |
(236) |
| GNPs@PEG/Ce6-human PD-L1 peptide nanoprobes
gold NPS(GNPs) |
Ce6 |
633 nm, (0.8 W/cm2) |
>100 nm |
–11.38 ± 3.89 mV |
HCC827 and A549 cells |
lung cancer (PDT–PTT) |
(237) |
| Ce6/Dox@NPs-cRGD (CDNR NPs) Cyclo(Arg-Gly-Asp-d-Phe-Cys)
(c(RGDfC), cRGD) |
Ce6 |
670 nm laser (0.25
W/cm2) |
112.6 nm |
–21.5 mV |
MCF-7 cells |
breast
cancer (PDT) |
(238) |
| CNPs-Ce6, Ce6 loaded chitosan
NPs (CNPs) |
Ce6 |
635 nm laser (50 mW/cm2) |
160–200 nm |
24.77 mV |
A549 cells |
lung cancer (PDT) |
(239) |
| G-chlorin e6 (glucose-conjugated chlorin e6) |
Ce6 |
664 nm laser (100 J/cm2) (150 mW/cm2). |
not defined |
not defined |
MKN45 cells and HT29 cells |
gastrointestinal cancer (PDT) |
(240) |
| Ce6 mediated PDT |
Ce6 |
690 nm NIR laser
irradiation (0.5 w/cm2) |
not defined |
not defined |
Lewis cells |
lung cancer
(PDT) |
(241) |
| Ce6 and IgG nanocomplexes (Chlorin e6 +
immunoglobulin G) |
Ce6 |
660 nm (80 mW/cm2) |
∼7 and ∼44 nm |
not defined |
GL261, a PD-L1 positive cell line |
glioma (PDT) |
(242) |
